Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

In this Discussion

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.

    Support MFO

  • Donate through PayPal

Sunbridge Capital Emerging Markets Fund (I class) to liquidate

497 1 fp0081452-1_497.htm

Sunbridge Capital Emerging Markets Fund
Institutional Class (Ticker Symbol: RIMIX)

A series of Investment Managers Series Trust II (the "Trust")

Supplement dated January 10, 2023 to the currently effective
Prospectus, Summary Prospectus and Statement of Additional Information ("SAI").

The Board of Trustees of the Trust has approved a Plan of Liquidation for the Sunbridge Capital Emerging Markets Fund (the "Fund"). The Plan of Liquidation authorizes the termination, liquidation and dissolution of the Fund. In order to perform such liquidation, effective immediately the Fund is closed to all new investment.

The Fund will be liquidated on or about February 10, 2023 (the "Liquidation Date"), and shareholders may redeem their shares until the Liquidation Date. On or promptly after the Liquidation Date, the Fund will make a liquidating distribution to its remaining shareholders equal to each shareholder's proportionate interest in the net assets of the Fund, in complete redemption and cancellation of the Fund's shares held by the shareholder, and the Fund will be dissolved.

In anticipation of the liquidation of the Fund, Sunbridge Capital Partners LLC, the Fund's advisor, may manage the Fund in a manner intended to facilitate its orderly liquidation, such as by raising cash or making investments in other highly liquid assets. As a result, during this time, all or a portion of the Fund may not be invested in a manner consistent with its stated investment strategies, which may prevent the Fund from achieving its investment objective.

Please contact the Fund at 1-877-771-7721 if you have any questions or need assistance.

Please file this Supplement with your records.
Sign In or Register to comment.